Cryofocus Medtech (Shanghai) Co. Ltd. Class H (HK:6922) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cryofocus Medtech has renewed its lease agreement with Ningbo Linfeng for three more years, starting January 2025. The company’s properties at the Linfeng Medical Technology Campus will continue to serve as plants and staff quarters. This transaction, considered a connected transaction under Hong Kong listing rules, involves significant shareholder interest but does not require independent shareholder approval.
For further insights into HK:6922 stock, check out TipRanks’ Stock Analysis page.